PubMed Health⌕ Search

Biomedical subjects

M Wiessler

Publications and source records attributed to M Wiessler.

148 records · Page 9Linked to original sources

DNA methylation in various rat tissues by the esophageal carcinogen N-nitrosomethyl-n-amylamine and six of its positional isomers.

The major pathway for the bioactivation of asymmetric N-nitrosomethylalkylamines involves cytochrome P-450 catalyzed alpha-C hydroxylation of the alkyl moiety opposite the methyl group, leading to the formation of a methanediazonium ion as the ultimate carcinogen. In the present study we have investigated the effect of the steric configuration of the pentyl chain on the bioactivation of N-nitrosomethylpentylamines in vivo. N-Nitrosomethyl-n-amylamine, a potent esophageal carcinogen, and six of its positional isomers were synthesized by nitrosation of the precursor amines. Overall yields and proportions of the respective Z- and E-isomers reflected the steric hindrance at the alpha-carbon of the pentyl groups. The extent of DNA methylation in various rat tissues after a single dose (0.1 mmol/kg; 6-h survival) of the isomers was determined by cation-exchange HPLC with fluorescence detection. (1) Among extrahepatic tissues, methylpurine concentrations were highest in esophagus, followed by the nasal and tracheal mucosa and lung. In these tissues, which are phylogenetically derived from the rat ventral entoderm, the relative extent of DNA methylation followed the same pattern for all isomers. (2) In the esophagus, formation of O6-methylguanine (O6-meG) was observed only for isomers with an unsubstituted alpha-methylene in the pentyl moiety, i.e., N-nitrosomethylisoamylamine, -n-amylamine, -(2-methylbutyl)amine, and -(2,2-dimethylpropyl)amine. (3) In trachea, methylated purines were also detectable after administration of the alpha-substituted isomer, N-nitrosomethyl(1-methylbutyl)amine. (4) Only nasal mucosa and lung were capable of bioactivating N-nitrosomethyl(1,2-dimethylpropyl)amine.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen.

Aristolochic acid II (AAII), one of the major components of the carcinogenic plant extract aristolochic acid, is known to be mutagenic and to form DNA adducts in vitro and in vivo. The major fluorescent DNA adduct formed upon xanthine oxidase mediated reduction in the presence of calf thymus (CT-) DNA or deoxyadenosine was isolated by means of preparative HPLC and identified by fluorescence, UV/vis absorbance, and 1H NMR spectroscopy as 7-(deoxy-adenosin-N6-yl)aristolactam II. As a model proximate carcinogen, N-chloroaristolactam II was prepared chemically from aristolactam II, the reduction product of AAII. This model compound was spectroscopically characterized and found to react directly with CT-DNA without any activation, forming the same deoxyadenosine adduct. HPLC analysis with fluorescence monitoring detected this adduct in vivo in the liver DNA of Wistar rats treated orally with AAII. These results confirm the anticipated metabolic activation mechanism of AAII as occurring via a cyclic nitrenium ion.

Adenine↗

Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

Limitations of low mol. wt anticancer drugs are short tumor exposure times and toxicity to normal tissue. Methotrexate (MTX) covalently linked to human serum albumin (HSA) as a macromolecular carrier caused tumor regressions concomitant with a favorable toxicity profile in a clinical phase I trial (Hartung et aL, Clin. Cancer Res., 1999, 5, 753). We examined the uptake, intracellular degradation, metabolism and thymidylate synthase (TS) inhibition of MTX-HSA in the T-cell leukemia line CCRF-CEM and the MTX transport resistant clone CCRF-CEM/MTX. The number of MTX molecules per albumin molecule was determined by electrospray mass spectrometry. A loading ratio (LR) of approximately 1.4 mol MTX/albumin revealed intact complexes with one and two MTX molecules/albumin. In the complex with an LR of 5.7, albumin with up to 16 MTX molecules was seen. MTX-HSA was taken up by CCRF-CEM cells via endocytosis and cleaved by lysosomal enzymes. Liberated MTX was a poor substrate of folylpolyglutamate synthetase and was exported into the medium. TS was inhibited and cell survival was impaired by MTX-HSA in a time- and concentration-dependent manner. CCRF-CEM/MTX cells exhibited a growth inhibition of 30-40% after MTX-HSA treatment, but no TS inhibition. The alternative uptake route via endocytosis enables MTX-HSA to overcome transport resistance to MTX.

Antimetabolites, Antineoplastic↗

Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathione.

Several agents with anticarcinogenic potential such as diethyldithiocarbamate (DDTC), lactose-DDTC, proline-dithiocarbamate (PDTC), its dimer proline-thiuramdisulfide (PTDS) and 4-carboxy-piperazine-TDS (4-pip-TDS) were investigated for their influence on the metabolism and the detoxication of aflatoxin B1 (AFB1) in vitro and in vivo. Aflatoxins are a group of mycotoxins produced by aspergillus species and are among the most important risk factors for hepatocellular carcinoma in certain areas of the world. AFB1 metabolism measured by the formation of tris-diol adducts showed that the thiuramdisulfides 4-carboxy-piperazine-TDS and PTDS were better inhibitors in vitro than the corresponding dithiocarbamates. Ex vivo studies in rats showed that dithiocarbamates (DTCs) including sugar linked lactose-DDTC decreased the formation of tris-diol adducts. Among the dithiocarbamates administered, DDTC showed a 40% inhibition whereas the other compounds showed only marginal effects. In vivo experiments on the formation of glutathione-adducts derived from AFB1-endo- and exo-epoxides showed that lactose-DDTC enhanced the formation of AFB1-GSH adducts, whereas PDTC, 4-pip-TDS, PTDS and DDTC displayed inhibitory effects. We conclude that DTCs may be promising agents in the chemoprevention of liver carcinogenesis caused by AFB1.

Aflatoxin B1↗